Preventing catheter related infections in haemodialysis patients

Current Opinion in Nephrology and Hypertension

Volumn 15, Issue 6, 2006, Pages 599-602

  Taal, Maarten W ^a,b   Fluck, Richard J ^a   McIntyre, Christopher W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b DERBY CITY GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFAZOLIN; CITRATE TRISODIUM; CITRIC ACID; EDETIC ACID; GENTAMICIN; HEPARIN; MINOCYCLINE; PLACEBO; POLYSPORIN; POVIDONE IODINE; PSEUDOMONIC ACID; RIFAMPICIN;

ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; CATHETER INFECTION; CLINICAL TRIAL; EDITORIAL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; PARESTHESIA; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

CATHETERS, INDWELLING; HUMANS; INFECTION CONTROL; RENAL DIALYSIS;

EID: 33750218116     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mnh.0000250685.51717.53     Document Type: Editorial

References (30)

1. Drueke T. Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant 2001; 7:25-28.
2. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999; 34:1114-1124.
3. Beathard GA. Catheter management protocol for catheter-related bacteremia prophylaxis. Seminars in Dialysis 2003; 16:403-405.
4. Schwab SJ, Sexton DJ. Management of infected cuffed central venous catheters used for hemodialysis. www.uptodate.com. [Accessed July 2006].
5. Schwab SJ, Weiss MA, Rushton F, et al. Multicenter clinical trial results with the LifeSite hemodialysis access system. Kidney Int 2002; 62:1026-1033.
6. Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. New Engl J Med 1986; 315:91-96.
7. Watanakunakorn C, Brandt J, Durkin P, et al. The efficacy of mupirocin ointment and chlorhexidine body scrubs in the eradication of nasal carriage of Staphylococcus aureus among patients undergoing long-term hemodialysis. Am J Infection Control 1992; 20:138-141.
8. Boelaert JR, Van Landuyt HW, Godard CA, et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol Dial Transplant 1993; 8:235-239.
9. Bommer J, Vergetis W, Andrassy K, et al. Elimination of Staphylococcus aureus in hemodialysis patients. ASAIO J 1995; 41:127-131.
10. Kluytmans JA, Manders MJ, van Bommel E, et al. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect Control Hosp Epidemiol 1996; 17:793-797.
11. Bloom BS, Fendrick AM, Chernew ME, et al. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis. Am J Kidney Dis 1996; 27:687-694.
12. Fong IW. Prevention of haemodialysis and peritoneal dialysis catheter related infection by topical povidone-iodine. Postgrad Med J 1993; 69 (Suppl 3):S15-S17.
13. Lok CE, Stanley KE, Hux JE, et al. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 2003; 14:169-179.
14. Johnson DW, MacGinley R, Kay TD, et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 2002; 17:1802-1807.
15. Annigeri R, Conly J, Vas S, et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Peritoneal Dial Int 2001; 21:554-559.
16. Deshpande LM, Fix AM, Pfaller MA, et al. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods. Diagn Microbiol Infect Dis 2002; 42:283-290.
17. Johnson DW, van Eps C, Mudge DW, et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol 2005; 16:1456-1462.
18. Andris DA, Krzywda EA, Edmiston CE, et al. Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheters. Nutrition 1998; 14:427-432.
19. Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002; 13:2133-2139.
20. McIntyre CW, Hulme LJ, Taal M, et al. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 2004; 66:801-805.
21. Nori US, Manoharan A, Yee J, et al. Low dose gentamicin as a catheter lock solution in the prevention of catheter related bacteraemia. Am J Kidney Dis 2006; 21:2184-2190.
22. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infectious Dis 2003; 36:1539-1544.
23. Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 2004; 19:1546-1551.
24. Weijmer MC, van den Dorpel MA, Van de Ven PJ, et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 2005; 16:2769-2777.
25. Duncan N, Singh S, Amao M, et al. A single centre randomised control trial of sodium citrate versus heparin line locks for cuffed central venous catheters [abstract]. J Am Soc Nephrol 2005; 16:451A.
26. Vercaigne LM, Sitar DS, Penner SB, et al. Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy 2000; 20:394-399.
27. Lambie SH, Hulme LJ, Taal M, et al. Prospective study of gentamicin locking of tunnelled dialysis catheters: the effect on infection rates and CRP [letter]. Kidney Int 2005; 67:378.
28. Fluck R, Taal M, McIntyre C. A single centre, one-year experience with antibiotic locking for tunnelled venous catheters [abstract]. Nephrol Dial Transplant 2006; 21 (Suppl 4):iv459-iv460.
29. Kim SH, Song KI, Chang JW, et al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int 2006; 69:161-164.
30. Chatzinikolaou I, Finkel K, Hanna H, et al. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am J Med 2003; 115:352-357.